Technology for improving the bioavailability of small molecules extracted from traditional Chinese medicines
Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3-triiodothyronine therapy
Patients with a known sensitivity to any of the individual ingredients should discuss this with their provider before starting
We further demonstrate that oxidative mitochondrial signalling can be used as a biomarker of response to fluoropyrimidine-based chemotherapy treatment in patients with CRC and may have clinical utility for stratifying patients at higher risk who could benefit from metabolically targeted combination therapies
High Quality Peptides Explore our wide selection of 99% + purified peptides , such as KLOW, BPC-157, GHK-CU, TB-500, MOTS-c and more